glp-1 brain JCI GLP-1 drugs protect brain health
Description
[1] Understanding these interconnected factors enables patients to optimize their treatment outcomes while minimizing discomfort

2024;39(S1)

Taste avoidance conditioning describes the reduction in the intake of novel taste or food that has been associated with a treatment that induces negative consequences e.g., including the effects of peripheral pain, lactose malabsorption or the effects LiCl [728]

Recent research has found that a persons genetic makeup may explain why some people do not respond to GLP-1 drugs

The main ingredient, berberine, can cause digestive side effects like diarrhoea, constipation, and an upset stomach

Among these, glucagon-like peptides secreted by intestinal enteroendocrine cells have gained attention for their roles in epithelial integrity and inflammation modulation
